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Abstract
Herein we disclose a scalable organo-catalytic direct arylation approach for the regio- and 
atroposelective synthesis of non-C2-symmetric 2,2′-dihydroxy-1,1′-binaphthalenes (BINOLs). In 
the presence of catalytic amounts of axially chiral phosphoric acids, phenols and naphthols are 
coupled with iminoquinones via a cascade process that involves sequential aminal formation, 
sigmatropic rearrangement, and rearomatization to afford enantiomerically enriched BINOL 
derivatives in good to excellent yields. Our studies suggest that the (local) symmetry of the 
initially formed aminal intermediate has a dramatic impact on the level of enantioinduction in the 
final product. Aminals with a plane of symmetry give rise to BINOL derivatives with significantly 
lower enantiomeric excess than unsymmetrical ones featuring a stereogenic center. Presumably 
asymmetric induction in the sigmatropic rearrangement step is significantly more challenging than 
during aminal formation. Sigmatropic rearrangement of the enantiomerically enriched aminal and 
subsequent rearomatization transfers the central chirality into axial chirality with high fidelity.
Biaryl compounds that exhibit axial chirality (i.e., hindered rotation about the C–C bond) are 
common among natural products, pharmaceuticals, ligands, and catalysts (Figure 1A). The 
ease of racemization in enantiopure biaryls depends on the magnitude of the rotational 
barrier, which is determined by both the size and number of substituents at the ortho 
positions flanking the aryl–aryl bond.1 During the past two decades, both C2- and non-C2-
symmetric axially chiral biaryl compounds1a–c (e.g., BINAP, BINOL, BINAM, NOBIN, and 
their derivatives; Figure 1A) have played key roles as ligands for transition metals in the 
development of catalytic enantioselective transformations.2 In addition to their role as 
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“privileged chiral catalysts”,2j recently it was recognized that controlling the chirality of 
functionalized biaryl structures will have enormous implications in the future development 
of pharmaceuticals.3 In view of the importance of biaryls, it is surprising that relatively few 
methods are available for their atroposelective synthesis in an operationally simple and 
scalable fashion.4 Current strategies5 include classical resolution of racemic biaryls, 
desymmetrization of preformed prochiral biaryls, dynamic kinetic resolution of rapidly 
racemizing preformed chiral biaryls,5c,i transition-metal-catalyzed aryl–aryl coupling,4b,5d 
de novo construction of an aromatic ring,5b,j and central-to-axial chirality exchange5f,h,k 
(Figure 1B).
As part of an ongoing program in the Kürti group to develop new and practical transition-
metal-free direct arylation methods for the preparation of highly functionalized symmetrical 
and unsymmetrical biaryls,6a,5h,6b we recently successfully exploited quinone and 
iminoquinone monoacetals as arylating agents to access both BINOL- and NOBIN-type 
functionalized biaryls that are atropoisomeric but non-C2-symmetric from phenols and 
naphthols under organocatalytic conditions (1 + 2 → 5; Figure 2A).6b We also briefly 
explored the possibility of using chiral BINOL-derived phosphoric acids as catalysts to 
obtain the biaryl products in an enantiomerically enriched form. Unfortunately, although 
moderate to good isolated yields were achieved, the level of enantioinduction was very poor 
(3–10% enantiomeric excess, ee), which we partially attributed to interference by the MeOH 
liberated during the formation of the mixed-acetal intermediate (1 + 2 → 3; Figure 2A);6b 
addition of 3 Å molecular sieves (MS) did not improve the ee. We observed similar 
interference by proton donors (i.e., H2O) during the catalytic synthesis of BINAM 
derivatives;5h in that case the addition of 4 Å MS was advantageous.
On the basis of these findings,6b we decided to redesign the quinone monoacetal coupling 
partner in a way that avoids the generation of a proton source (i.e., MeOH), thereby 
removing this potentially detrimental factor from the catalytic cycle.7 We selected readily 
available N-sulfonyl-protected iminoquinones as substrates, as these were expected to 
undergo acid-catalyzed in situ aminal formation8 and subsequent [3,3]-rearrangement/
rearomatization (Figure 2B). In contrast, a 1,4-addition mechanism was recently proposed 
by Tan and co-workers for a related reaction (Figure 2C).5k We were pleased to observe that 
a 10 mol % loading of chiral phosphoric acid 7b catalyzed the coupling of 6a with 2a under 
mild conditions and led to the formation of functionalized biaryl 9a in excellent isolated 
yield with 49% ee. Encouraged by this initial result, we conducted a survey of structurally 
diverse BINOL-derived chiral phosphoric acid catalysts2d,9 and solvents to find the optimum 
conditions that maximize the enantiomeric excess of the product (Table 1; see the 
Supporting Information (SI) for details).
On the basis of the optimization studies described in Table 1, we selected DCE as the 
preferred solvent, chiral phosphoric acid 7c (at 10 mol % loading) as the preferred catalyst, 
and either 25 or 50 °C as the optimum reaction temperature. At first we evaluated the 
coupling of iminoquinone 6a with 14 structurally different hydroxyarenes, including 11 
naphthols (Table 2, entries 1–11) and three monocyclic phenols (Table 2, entries 12–14).
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For 2-naphthols, the biaryl products were formed in good to excellent yields, and the 
observed enantioselectivities ranged between 78 and 96% ee. No clear pattern showing how 
electron-withdrawing and electron-donating groups on the naphthalene ring influence the 
level of enantioinduction can be discerned.
The nearly perfect enantioselectivity (99% ee) obtained during the formation of terphenyl 
compound 9ea’ from 2,3-dihydroxynapthalene (Table 2, entry 15) is remarkable and 
suggests that significant substrate stereocontrol occurs as the second biaryl linkage is 
established (see the discussion in the SI).
With one exception (Table 2, entry 14), monocyclic phenols afforded good levels of 
enantioinduction (entries 12 and 13). In a few cases (entries 1 and 5), using chlorobenzene 
as the solvent instead of DCE improved the enantioselectivity.
Next, we explored how structural changes (i.e., symmetry as well as size and nature of the 
substituents) in the iminoquinone (6b–j) influence the yield and enantioselectivity of the 
biaryl product (Table 3). Among the unsymmetrical iminoquinones 6b–e that were coupled 
with 2,3-dihydroxynaphthalene (2e), the presence of a large substituent (i.e, i-Pr) at the ortho 
position of the N-Ts imine moiety led to a somewhat lower isolated yield and ee for 9ed 
(entry 18) relative to isomeric 9eb and 9ec (entries 16 and 17) with a smaller Me substituent 
at the ortho position. Presumably, the larger i-Pr group slows aminal formation and lowers 
the enantioselectivity of this step. The nature of the acyl/sulfonyl group on the N atom also 
appears to be important: the ee increases as more electron-withdrawing groups are used (i.e., 
Ts ≥ Ms > Ac > p-NO2-benzoyl; compare 9aa in Table 1 with entries 16, 23, and 24 in Table 
2).
The most dramatic drop in the level of enantioinduction occurred when symmetrical (6f) and 
pseudosymmetrical (6g) iminoquinones were utilized as coupling partners (Table 3, entries 
20 and 21). In fact, the poor ee’s observed for biaryls 9ef and 9eg provided us with a very 
valuable clue that helped us establish whether indeed aminal formation as opposed to 1,4-
addition is involved in the key stereochemistry-determining step.
On the basis of several experimental findings (Figure 3), it appears that in catalytic 
enantioselective processes where sequential chirality-transfer steps are involved, the highest 
level of enantioinduction will most likely take place in those cases where the catalyst does 
not “miss/skip” an opportunity to transfer chiral information. One way to “lose” or “skip” an 
opportunity for chirality transfer is when one or more symmetrical intermediates are formed 
along the pathway (see Figure 3A,C). Naturally, symmetrical (i.e., prochiral) intermediates 
can be desymmetrized using chiral catalysts, but the level of enantioinduction in these 
desymmetrizations must be very high, which is often difficult to achieve. In particular, 
organocatalytic asymmetric versions of the Claisen rearrangement are challenging, and there 
are only a few highly enantioselective examples in the literature.10
In light of the enantioinduction levels for biaryls 9ea (96% ee) and 9eg (21% ee), we can 
make a convincing mechanistic case for the involvement of sequential aminal formation/
[3,3]-rearrangement. Figure 4 clearly shows that if a direct 1,4-addition were operational, the 
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influence of the highlighted extra methyl group could not account for the dramatic loss of 
enantioselectivity.
In conclusion, we have successfully developed a practical organocatalytic atroposelective 
synthesis of non-C2-symmetric BINOL derivatives starting from readily available 
hydroxyarenes and iminoquinones. The nearly two dozen axially chiral and structurally 
diverse functionalized biaryl products represent new chemical space and are expected to find 
broad utility in asymmetric catalysis, drug discovery, and materials science.
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Figure 1. 
Organocatalytic atroposelective direct arylation of hydroxyarenes to afford non-C2-
symmetric BINOLs.
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Figure 2. 
Development of our catalytic atroposelective direct arylation approach to non-C2-symmetric 
BINOL derivatives (A,6b B) and a recent report by Tan and co-workers (C).5k
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Figure 3. 
Symmetries of intermediates in chirality transfer processes have a dramatic impact on the 
final products’ ee.
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Figure 4. 
Case is made for the aminal-formation/[3,3]-rearrangement sequence as opposed to a direct 
1,4-addition.
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Table 1
Catalyst Screen for the Atroposelective Synthesis of 9a from 6a and 2a
Entrya Solvent Time (h) erb ee (%)
1 CH2Cl2 48 88.5:11.5 77
2 toluene 48 86:14 72
3 1,2-dichloroethane (DCE) 48 94:6 88
4 CHCl3 48 90.5:9.5 81
5 chlorobenzene 84 97:3 94
6 1,3-di-CF3-benzene 60 93:7 86
7c 1,2-dichloroethane (DCE) 24 94:6 88
8c chlorobenzene 48 96:4 92
9d 1,2-dichloroethane (DCE) 8 91:9 82
10c,e 1,2-dichloroethane(DCE) 100 88.5:11.5 77
a
Reaction conditions: 2a (0.075 mmol), 6a (0.05 mmol), cat. (10 mol %), solvent (1 mL). Reactions were stopped when all of the 6a was 
consumed.
b
Enantiomeric ratios were determined by HPLC analysis.
c
Reacted at 50 °C.
d
Reacted at 80 °C.
eUsing 5 mol % 7c.
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Table 2
Exploration of the Substrate Scope by Coupling of 6a with Structurally Diverse Hydroxyarenes
a
Reaction conditions: 2 (0.225 mmol), 6a (0.15 mmol), cat. 7c (10 mol %), DCE or chlorobenzene (3 mL), rt or 50 °C, unless indicated otherwise.
b
Reactions were stopped when all of the 6a was consumed.
c
Determined by HPLC analysis.
dCompound 9ea was obtained in 92% yield with 94% ee when the reaction was performed on a 3 mmol scale in chlorobenzene.
eAt 50 °C over 2 h the reaction proceeded in 97% yield to afford 9na with 21% ee.
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f2a:6a ratio = 2.5:1; the absolute configuration of 9ea’ is (R,R).
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Table 3
Expansion of the Substrate Scope by Coupling of Structurally Diverse Iminoquinones
a
Reaction conditions: 2 (0.225 mmol), 3a (0.15 mmol), cat. 1c (10 mol %), DCE or chlorobenzene (3 mL), rt or 50 °C.
b
Reactions were stopped when all of the 6b–j was consumed.
c
Determined by HPLC analysis.
dCompound 9aj’ was found to racemize easily: even at room temperature overnight, the initial 25% ee decreased to 12% ee.
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